The Stat5b Antibody is typically a mouse monoclonal IgG1 antibody. For instance, the Santa Cruz Biotechnology product (Catalog #sc-1656) targets an epitope mapping between amino acids 750–779 at the C-terminus of mouse-origin Stat5b, ensuring cross-reactivity with human, rat, and other species like equine and porcine . This specificity allows researchers to study STAT5B in both murine models and human tissues.
In contrast, the R&D Systems antibody (Catalog #MAB1584) employs a distinct epitope, validated through Western blot and flow cytometry experiments in human cell lines (e.g., HeLa, Daudi) and knockout cell lines to confirm specificity .
The Stat5b Antibody is versatile, supporting multiple experimental techniques:
Western Blot (WB): Detects STAT5B at approximately 90–91 kDa under reducing conditions. Knockout cell line validation (e.g., HeLa STAT5b KO) ensures no cross-reactivity with STAT5A .
Immunoprecipitation (IP): Used to isolate STAT5B complexes for downstream analysis, as demonstrated in HAP1 human cells .
Immunofluorescence (IF): Localizes STAT5B in cellular compartments, aiding studies on nuclear translocation post-cytokine stimulation .
Flow Cytometry: The R&D Systems antibody (MAB1584) enables detection of STAT5B in Jurkat T cells, distinguishing it from isotype controls .
ELISA: The Santa Cruz antibody facilitates quantification of STAT5B in lysates or sera .
STAT5B is implicated in BCR/ABL-positive leukemias, where its activation suppresses interferon (IFN)-α/γ signaling, promoting tumor growth. Studies using Stat5b-deficient mice revealed impaired leukemic colony formation, underscoring STAT5B’s role in oncogenesis . Antibodies like sc-1656 (Santa Cruz) have been employed to confirm STAT5B activation in patient-derived leukemia cells.
Gain-of-function mutations in STAT5B have been linked to early-onset immune disorders, including atopic dermatitis and mast cell-driven inflammation. Functional assays using patient-derived T cells demonstrated hyperresponsiveness to cytokines, with the Stat5b Antibody validating elevated protein levels .
STAT5B exhibits sexual dimorphism in liver gene expression, regulating metabolism and detoxification. The antibody has been used to study gender-specific STAT5B activity in rodent models .
| Cell Line | Detection | Band Size | Conditions |
|---|---|---|---|
| HeLa | STAT5B | 90 kDa | Reducing |
| Daudi | STAT5B | 90 kDa | Reducing |
| STAT5b KO HeLa | None | — | Reducing |